ADA WONG

Ada Wong is the VP of Intellectual Property at InterVenn Biosciences where she is responsible for developing the global IP strategy.  InterVenn is a private stage company focused on interrogation of the glycoproteome to develop clinical insights, biomarkers, diagnostics and therapeutics across multiple disease states.  Having served in-house and in private practice, Ada has over 17 years of experience providing IP counseling and managing portfolios at different stages of the product
development continuum.

Prior to joining InterVenn, Ada was a Senior IP Counsel at Jazz Pharmaceuticals, where she devised and implemented global IP strategy for marketed drugs and
clinical-phase products in the oncology and neuroscience space and spearheaded IP diligence for complex transactions.  

Before assuming her position at Jazz, Ada was a Senior Patent Counsel at
Johnson & Johnson, where she supported the Infectious Disease therapeutic area, Computational Science and Emerging Science groups. 

Ada has a J.D. from Santa Clara University, an M.S. in Biotechnology with an emphasis in Bioinformatics from the Johns Hopkins University, and a B.S. in
Molecular Cell Biology from U.C. Berkeley.